Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.2M Sell
210,965
-87,079
-29% -$10.2M 0.14% 116
2026
Q1
$35.8M Sell
298,044
-73,223
-20% -$8.45M 0.18% 100
2025
Q4
$39M Buy
371,267
+8,280
+2% +$777K 0.2% 96
2025
Q3
$30.5M Sell
362,987
-92,913
-20% -$7.65M 0.16% 115
2025
Q2
$36M Sell
455,900
-85,084
-16% -$6.76M 0.2% 104
2025
Q1
$48.7M Sell
540,984
-14,644
-3% -$1.37M 0.23% 79
2024
Q4
$55M Buy
555,628
+19,052
+4% +$1.96M 0.34% 71
2024
Q3
$61.2M Buy
536,576
+94,981
+22% +$11.3M 0.22% 80
2024
Q2
$54.8M Buy
441,595
+70,985
+19% +$9.14M 0.22% 79
2024
Q1
$48.9M Buy
+370,610
New +$45.7M 0.18% 78

Other funds holding MRK

M&G plc's MRK Position: Q2 2026 in Review

M&G plc reduced its Merck (MRK) stake by 29% in Q2 2026, selling an estimated $10.2M and leaving 210,965 shares worth $27.2M. The position accounts for 0.14% of the portfolio, ranked #116.

M&G plc first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. The position peaked at $61.2M in Q3 2024. 3,836 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • M&G plc held 210,965 shares of Merck worth $27.2M as of Q2 2026.
  • M&G plc sold 87,079 Merck shares in Q2 2026, an estimated $10.2M.
  • Merck made up 0.14% of M&G plc's portfolio in Q2 2026, its #116 holding.
  • M&G plc first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • M&G plc's Merck position peaked at $61.2M in Q3 2024.
  • 3,836 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.